A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data.
暂无分享,去创建一个
Horacio Pérez-Sánchez | Antonio-Jesús Banegas-Luna | José P Cerón-Carrasco | H. Pérez‐Sánchez | J. P. Cerón-Carrasco | A. Banegas-Luna
[1] Yu-chian Chen. Beware of docking! , 2015, Trends in pharmacological sciences.
[2] Alexandre Tkatchenko,et al. Quantum-chemical insights from deep tensor neural networks , 2016, Nature Communications.
[3] Alexander D. MacKerell,et al. Computer-Aided Drug Design Methods. , 2017, Methods in molecular biology.
[4] Wolfgang H. B. Sauer,et al. Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity , 2003, J. Chem. Inf. Comput. Sci..
[5] Danishuddin,et al. Descriptors and their selection methods in QSAR analysis: paradigm for drug design. , 2016, Drug discovery today.
[6] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[7] Jacob de Vlieg,et al. Comparative Analysis of Pharmacophore Screening Tools , 2012, J. Chem. Inf. Model..
[8] Zygmunt S Derewenda,et al. Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor. , 2012, Biochemistry.
[9] Beáta Flachner,et al. Combination of 2D/3D Ligand-Based Similarity Search in Rapid Virtual Screening from Multimillion Compound Repositories. Selection and Biological Evaluation of Potential PDE4 and PDE5 Inhibitors , 2014, Molecules.
[10] Egon L. Willighagen,et al. The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..
[11] Kohei Ichikawa,et al. Virtual Screening Techniques and Current Computational Infrastructures. , 2016, Current pharmaceutical design.
[12] Rona R. Ramsay,et al. A perspective on multi-target drug discovery and design for complex diseases , 2018, Clinical and Translational Medicine.
[13] Eugene N. Muratov,et al. Chalcone Derivatives: Promising Starting Points for Drug Design , 2017, Molecules.
[14] Xiaofeng Liu,et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..
[15] Matthias Rarey,et al. Similarity searching in large combinatorial chemistry spaces , 2001, J. Comput. Aided Mol. Des..
[16] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[17] David Ryan Koes,et al. ZINCPharmer: pharmacophore search of the ZINC database , 2012, Nucleic Acids Res..
[18] Deepak Singla,et al. Open source software and web services for designing therapeutic molecules. , 2013, Current topics in medicinal chemistry.
[19] Jonathan J. Chen,et al. Developing an in silico pipeline for faster drug candidate discovery: Virtual high throughput screening with the Signature molecular descriptor using support vector machine models , 2017 .
[20] Pierre Tufféry,et al. wwLigCSRre: a 3D ligand-based server for hit identification and optimization , 2009, Nucleic Acids Res..
[21] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[22] Álvaro Cortés Cabrera,et al. A reverse combination of structure-based and ligand-based strategies for virtual screening , 2012, Journal of Computer-Aided Molecular Design.
[23] Kwong-Sak Leung,et al. USR-VS: a web server for large-scale prospective virtual screening using ultrafast shape recognition techniques , 2016, Nucleic Acids Res..
[24] Leonardo L. G. Ferreira,et al. Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.
[25] John Steele,et al. Drug-like properties: guiding principles for design - or chemical prejudice? , 2004, Drug discovery today. Technologies.
[26] Xin Yan,et al. LBVS: an online platform for ligand-based virtual screening using publicly accessible databases , 2014, Molecular Diversity.
[27] Keun Woo Lee,et al. Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations , 2018, BMC Cancer.
[28] David Baker,et al. Accurate protein structure modeling using sparse NMR data and homologous structure information , 2012, Proceedings of the National Academy of Sciences.
[29] Gang Fu,et al. PubChem Substance and Compound databases , 2015, Nucleic Acids Res..
[30] Byunghan Lee,et al. Deep learning in bioinformatics , 2016, Briefings Bioinform..
[31] José L. Medina-Franco,et al. Database fingerprint (DFP): an approach to represent molecular databases , 2017, Journal of Cheminformatics.
[32] Narges Zolfaghari. Molecular docking analysis of nitisinone with homogentisate 1,2 dioxygenase , 2017, Bioinformation.
[33] Theodora Katsila,et al. Computational approaches in target identification and drug discovery , 2016, Computational and structural biotechnology journal.
[34] K. P. Soman,et al. Ligand-Based Virtual Screening using Random Walk Kernel and Empirical Filters , 2015 .
[35] Vijay S. Pande,et al. SIML: A Fast SIMD Algorithm for Calculating LINGO Chemical Similarities on GPUs and CPUs , 2010, J. Chem. Inf. Model..
[36] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[37] Xia Wang,et al. Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach , 2014, Evidence-based complementary and alternative medicine : eCAM.
[38] Thomas Girke,et al. ChemMine. A Compound Mining Database for Chemical Genomics1 , 2005, Plant Physiology.
[39] Jennifer L Miller,et al. Recent developments in focused library design: targeting gene-families. , 2006, Current topics in medicinal chemistry.
[40] Maykel Cruz-Monteagudo,et al. Generalized Molecular Descriptors Derived From Event-Based Discrete Derivative. , 2016, Current pharmaceutical design.
[41] Serdar Durdagi,et al. Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development , 2017, Journal of enzyme inhibition and medicinal chemistry.
[42] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[43] Jean-Louis Reymond,et al. Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 , 2012, J. Chem. Inf. Model..
[44] Olivier Sperandio,et al. One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. , 2013, Drug discovery today.
[45] Gnanendra Shanmugam,et al. Computer-Aided Drug Discovery in Plant Pathology , 2017, The plant pathology journal.
[46] Richard Grunzke,et al. Portals and Web-Based Resources for Virtual Screening. , 2016, Current drug targets.
[47] Donato Rigante,et al. Lung Involvement in Children with Hereditary Autoinflammatory Disorders , 2016, International journal of molecular sciences.
[48] Peter Willett. Special Issue: Chemoinformatics , 2016, Molecules.
[49] Stefano Forli,et al. Charting a Path to Success in Virtual Screening , 2015, Molecules.
[50] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[51] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[52] Ke Ding,et al. Discovery of pteridin-7(8H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) kinase T790M/L858R mutant. , 2013, Journal of medicinal chemistry.
[53] Loriano Storchi,et al. New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..
[54] Hualiang Jiang,et al. SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration. , 2011, Journal of medicinal chemistry.
[55] Lars Ridder,et al. Revisiting the Rule of Five on the Basis of Pharmacokinetic Data from Rat , 2011, ChemMedChem.
[56] Arnim Hellweg,et al. TmoleX—A graphical user interface for TURBOMOLE , 2010, J. Comput. Chem..
[57] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[58] John Davies,et al. Design of small molecule libraries for NMR screening and other applications in drug discovery. , 2002, Current topics in medicinal chemistry.
[59] Narges Zolfaghari,et al. Competitive rational inhibitor design to 4-maleylaceto-acetate isomerase , 2017, Bioinformation.
[60] Olivier Michielin,et al. SwissSimilarity: A Web Tool for Low to Ultra High Throughput Ligand-Based Virtual Screening , 2016, J. Chem. Inf. Model..
[61] David Ryan Koes,et al. Pharmer: Efficient and Exact Pharmacophore Search , 2011, J. Chem. Inf. Model..
[62] R. Jackson,et al. Homology-modelling protein-ligand interactions: allowing for ligand-induced conformational change. , 2010, Journal of molecular biology.
[63] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[64] Joshua M. Stuart,et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. , 2018, Cell.
[65] Abhinav Vishnu,et al. Deep learning for computational chemistry , 2017, J. Comput. Chem..
[66] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[67] Raman Sharma,et al. ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics , 2010, J. Comput. Aided Mol. Des..
[68] R. Todeschini,et al. Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .
[69] Kunal Roy,et al. How far can virtual screening take us in drug discovery? , 2013, Expert opinion on drug discovery.
[70] Z R Li,et al. MODEL—molecular descriptor lab: A web‐based server for computing structural and physicochemical features of compounds , 2007, Biotechnology and bioengineering.
[71] Zhiyong Lu,et al. The CHEMDNER corpus of chemicals and drugs and its annotation principles , 2015, Journal of Cheminformatics.
[72] Arno Formella,et al. Superimposé: a 3D structural superposition server , 2008, Nucleic Acids Res..
[73] M. L. Connolly. Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.
[74] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[75] Adel Hamza,et al. SABRE: Ligand/Structure-Based Virtual Screening Approach Using Consensus Molecular-Shape Pattern Recognition , 2014, J. Chem. Inf. Model..
[76] Ganesh Chandra Sahoo,et al. In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance , 2017, Antimicrobial Agents and Chemotherapy.
[77] D. Dripps,et al. DNA bending induced by the catabolite activator protein allows ring formation of a 144 bp DNA. , 1987, Journal of biomolecular structure & dynamics.
[78] Antony J. Williams,et al. ChemSpider:: An Online Chemical Information Resource , 2010 .
[79] Ingo Muegge,et al. 3D virtual screening of large combinatorial spaces. , 2015, Methods.
[80] Feroz Khan,et al. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity , 2018, Scientific Reports.
[81] Cheng Luo,et al. Development of a novel class of B-Raf(V600E)-selective inhibitors through virtual screening and hierarchical hit optimization. , 2012, Organic & biomolecular chemistry.
[82] Xiaofeng Liu,et al. SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening , 2011, J. Chem. Inf. Model..
[83] Christian N. S. Pedersen,et al. Methods for Similarity-based Virtual Screening , 2013, Computational and structural biotechnology journal.
[84] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[85] Renu Vyas,et al. Role of Open Source Tools and Resources in Virtual Screening for Drug Discovery. , 2015, Combinatorial chemistry & high throughput screening.
[86] W. Graham Richards,et al. Ultrafast shape recognition to search compound databases for similar molecular shapes , 2007, J. Comput. Chem..
[87] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[88] Andrzej Kolinski,et al. Protein structure prediction: Combining de novo modeling with sparse experimental data , 2007, J. Comput. Chem..
[89] Enrico Glaab,et al. Building a virtual ligand screening pipeline using free software: a survey , 2015, Briefings Bioinform..
[90] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[91] Pedro M. Alzari,et al. A potent new mode of β-lactamase inhibition revealed by the 1.7 Å X-ray crystallographic structure of the TEM-1–BLIP complex , 1996, Nature Structural Biology.
[92] Ruth Brenk,et al. Mining the ChEMBL Database: An Efficient Chemoinformatics Workflow for Assembling an Ion Channel-Focused Screening Library , 2011, J. Chem. Inf. Model..
[93] William J. Welsh,et al. Avalanche for shape and feature-based virtual screening with 3D alignment , 2015, Journal of Computer-Aided Molecular Design.
[94] Daisuke Kihara,et al. Three-Dimensional Compound Comparison Methods and Their Application in Drug Discovery , 2015, Molecules.
[95] Sumudu P Leelananda,et al. Computational methods in drug discovery , 2016, Beilstein journal of organic chemistry.
[96] Douglas R. Houston,et al. UFSRAT: Ultra-Fast Shape Recognition with Atom Types –The Discovery of Novel Bioactive Small Molecular Scaffolds for FKBP12 and 11βHSD1 , 2015, PloS one.
[97] Salman Akhtar,et al. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study. , 2017, Current computer-aided drug design.
[98] Jorge Cortés,et al. SEABED: Small molEcule activity scanner weB servicE baseD , 2014, Bioinform..
[99] Benjamin A. Ellingson,et al. Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..
[100] Jean-Louis Reymond,et al. Chemical Space: Big Data Challenge for Molecular Diversity. , 2017, Chimia.
[101] Dong-Sheng Cao,et al. ChemoPy: freely available python package for computational biology and chemoinformatics , 2013, Bioinform..
[102] J. Hughes,et al. Physiochemical drug properties associated with in vivo toxicological outcomes. , 2008, Bioorganic & medicinal chemistry letters.
[103] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[104] Xi Dai,et al. HybridSim‐VS: a web server for large‐scale ligand‐based virtual screening using hybrid similarity recognition techniques , 2017, Bioinform..